0001217234-20-000059.txt : 20200507 0001217234-20-000059.hdr.sgml : 20200507 20200507192919 ACCESSION NUMBER: 0001217234-20-000059 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200506 FILED AS OF DATE: 20200507 DATE AS OF CHANGE: 20200507 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HAGSTROM WILLIAM A CENTRAL INDEX KEY: 0001042875 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36536 FILM NUMBER: 20858239 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CareDx, Inc. CENTRAL INDEX KEY: 0001217234 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 943316839 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 TOWER PLACE STREET 2: 9TH FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-287-2300 MAIL ADDRESS: STREET 1: 1 TOWER PLACE STREET 2: 9TH FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: XDx, Inc. DATE OF NAME CHANGE: 20071010 FORMER COMPANY: FORMER CONFORMED NAME: EXPRESSION DIAGNOSTICS INC DATE OF NAME CHANGE: 20030203 4 1 wf-form4_158889414197989.xml FORM 4 X0306 4 2020-05-06 0 0001217234 CareDx, Inc. CDNA 0001042875 HAGSTROM WILLIAM A C/O CAREDX, INC. 1 TOWER PLACE, 9TH FLOOR SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2020-05-06 4 M 0 15000 1.22 A 30385 D Common Stock 2020-05-06 4 S 0 15000 29.1219 D 15385 D Stock Option (right to buy) 1.22 2020-05-06 4 M 0 15000 1.22 D 2027-07-13 Common Stock 15000.0 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.77 to $29.56, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. 1/12th of the shares subject to the option vested on August 13, 2017 and 1/12th of the shares subject to the option vested monthly thereafter through July 13, 2018. /s/ Peter Maag as attorney-in-fact for William A. Hagstrom 2020-05-07